Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal Study to Evaluate the Safety and Effectiveness of Exablate Model 4000 Using Microbubble Resonators to Temporarily Mediate Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors

NCT05383872 is registered in ClinicalTrials.gov with InSightec as lead sponsor.

NCT NCT05383872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05383872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal Study to Evaluate the Safety and Effectiveness of Exablate Model 4000 Using Microbubble Resonators to Temporarily Mediate Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
Lead sponsor
InSightec
Phase
Not applicable
Overall status
Completed
Start date
August 8, 2022
Completion date
March 5, 2025
Enrollment
71 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, glioma, liquid biopsy